Again, I'm not in the unit that approves drugs. In the United States our goal is to approve most drugs in a ten-month timeline. For certain drugs that are for serious or life-threatening diseases, we can do it on an accelerated pace in a six-month timeline. But we always ensure that the review of safety is completed before we make a decision to approve a drug. If we need to ask the company for more information, we will.
I'm not aware of the particular conference you're discussing, but we can try to get some information on that for you.